MedPath
NMPA Approval

Fudosteine Oral Solution

国药准字H20247310

December 11, 2024

国药准字H20233361

Drug Information

福多司坦口服溶液

口服溶液剂

120ml:9.6g

化学药品

December 11, 2024

Company Information

Applicant Company

中国(江苏)自由贸易试验区苏州片区苏州工业园区集贤街11号南楼2-3层

Manufacturing Company

浙江省兰溪市康恩贝大道1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

福多司坦口服溶液 - NMPA 批准文号 | MedPath